Table of Contents

Abstracts

Discovery and pharmacological characterization of OMO-1, a potent, highly selective and orally bioavailable MET kinase inhibitor
Timothy P.S. Perera

• PDF

Abstracts

LncRNA as a Therapeutic Target for Angiogenesis
Jue Wang

• PDF

Abstracts

Effectiveness of second and third generation TKIs (Dasatinib, Nilotinib and Ponatinib) in Chronic Myeloid Leukemia Treatment
Manoj Kumar Panigrahi

• PDF

Abstracts

The Role of Mutations in BRCA1 BRCA2 and Other Factors Involved in Homologous Recombination in Cancer Development and Treatment PARP Inhibitors and Beyond
Omkar Dasgupta

• PDF

Editorial

Journal of Molecular Cancer
Journal of Molecular Cancer

• PDF